4//SEC Filing
CymaBay Therapeutics, Inc. 4
Accession 0001042074-17-000008
CIK 0001042074operating
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 1:16 PM ET
Size
5.5 KB
Accession
0001042074-17-000008
Insider Transaction Report
Form 4
Dickinson Klara
SVP, Regulatory Affairs & QA
Transactions
- Award
Stock Option (right to buy)
2017-06-28+200,000→ 200,000 totalExercise: $5.50Exp: 2027-06-27→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest according to the following schedule: 25% of the shares subject to the option shall vest on June 26, 2018, and the remaining of the shares shall vest in equal monthly installments over the next 36 months.
Documents
Issuer
CymaBay Therapeutics, Inc.
CIK 0001042074
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001042074
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 1:16 PM ET
- Size
- 5.5 KB